Helixmith
id:
helixmith-289-11686741
title:
Helixmith
text:
Helixmith Co. LTD. is a biotechnology company located in Seoul, South Korea with US presence in San Diego. The company has an extensive gene therapy pipeline, including a non-viral plasmid DNA program for neuromuscular and ischemic disease, a CAR-T program targeting several different types of solid tumors, and an AAV vector program targeting neuromuscular diseases. Helixmith’s lead gene is Engensis (VM202), currently in phase III diabetic peripheral neuropathy (DPN) in the US. Engensis (VM202) i
brand slug:
wiki
category slug:
encyclopedia
description:
South Korean biotechnology company
original url:
https://en.wikipedia.org/wiki/Helixmith
date created:
date modified:
2024-03-29T17:02:19Z
main entity:
{"identifier":"Q7934841","url":"https://www.wikidata.org/entity/Q7934841"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/ab/Helixmith.jpg","width":3024,"height":4032}
fields total:
13
integrity:
15